NCT01580345 - Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India. | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 6, 2016

Study Completion Date

December 9, 2016

Conditions

Pregnancy

Interventions

DIETARY_SUPPLEMENT

Docosa-hexaenoic acid (DHA)

400 mg/day of Docosa-hexaenoic Acid (algal DHA) will given to the pregnant women (in the active group) from ≤20 weeks of gestation through delivery.

DIETARY_SUPPLEMENT

Placebo

400 mg/day of placebo (corn/soy oil) will be given to the pregnant women from ≤20 weeks of gestation through delivery.

Trial Locations (1)

KLEUs Jawaharlal Nehru Medical College- Prabhakar Kore Charitable Hospital, Belagavi

All Listed Sponsors

collaborator

Department of Science and Technology, Government of India

UNKNOWN

collaborator

Jawaharlal Nehru Medical College

OTHER

lead

Centre for Chronic Disease Control, India

OTHER